It is found that PD is a biologically and clinically heterogeneous disease that requires biomarker-directed and genotype-stratified therapeutic development and major translational issues are critically evaluated, including challenges related to blood-brain barrier penetration, target specificity, and long-term safety o...
Abid Khan, T. Jawaid, Z. Urrehman et al.· Experimental Neurology· 0 citations
INTRODUCTION
Breast cancer remains a major global health concern, creating an urgent need for safer and more effective treatments. This study aimed to identify novel progesterone receptor modulators as potential candidates for targeted breast cancer therapy using an integrated in silico approach.
MATERIALS AND METHOD...
Shiom Mane, B. Udugade, Sachinkumar Patil et al.· Current Cancer Drug Targets· 0 citations
The Alzheimer's Disease (AD) lacks effective disease-modifying therapy, even though amyloid-targeting immunotherapies have recently been applied clinically. N-methyl-D-Aspartate Receptors (NMDARs) play a central yet mechanistically complicated role in the pathophysiology of AD, where they are convergence points of amyl...
Md Sirajuddin Khan, A. M. Ashesh, Mithul V. Mammen et al.· Current Neuropharmacology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.